Why do I have necrobiosis on my legs?
Necrobiosis lipoidica is a rare skin condition causing shiny, reddish-brown patches on the legs, strongly linked to diabetes and abnormal blood sugar levels. While the exact cause is unknown, it involves inflammation and collagen breakdown in the skin, requiring management of underlying metabolic conditions and specialized dermatological care.
Jump To Section
Understanding Necrobiosis Lipoidica
Necrobiosis lipoidica (NL), also known as necrobiosis lipoidica diabeticorum when associated with diabetes, is a rare chronic skin condition that typically appears as distinctive patches on the legs. These lesions start as small, firm, reddish-brown bumps that gradually expand into larger, waxy, yellowish-brown plaques with a shiny, almost translucent appearance. The condition affects less than 1% of people with diabetes, though it can also occur in individuals without diabetes.
The name 'necrobiosis' refers to the degeneration and death of connective tissue cells (particularly collagen) in the dermis, while 'lipoidica' describes the yellowish, fatty appearance of the affected areas. Despite its alarming name, this condition is not life-threatening, though it can be cosmetically concerning and occasionally painful or ulcerated.
The Diabetes Connection
The relationship between necrobiosis lipoidica and diabetes is complex and significant. Approximately 60-70% of people with NL have diabetes or prediabetes, making it one of the most important associations to understand. The condition often appears before diabetes is formally diagnosed, sometimes serving as an early warning sign of metabolic dysfunction.
Necrobiosis Lipoidica and Diabetes Association
| Patient Group | Prevalence | Typical Onset | Management Focus | |
|---|---|---|---|---|
| Type 1 Diabetes | Type 1 Diabetes | 0.3-1.2% | Often before age 30 | Insulin therapy, wound prevention |
| Type 2 Diabetes | Type 2 Diabetes | 0.3% | Variable, usually after diagnosis | Glycemic control, vascular health |
| Prediabetes | Prediabetes | Unknown, but significant | May precede diabetes diagnosis | Lifestyle modification, monitoring |
| No Diabetes | No Diabetes | 30-40% of NL cases | Any age, peaks 30-40 years | Treat skin, screen for diabetes |
The relationship between necrobiosis lipoidica and glucose metabolism varies significantly across patient populations.
Research suggests that chronic hyperglycemia (elevated blood sugar) contributes to microangiopathy, or damage to small blood vessels, which may trigger the inflammatory cascade leading to NL. The glycation of proteins in blood vessel walls and surrounding tissues can impair circulation and promote the characteristic tissue changes seen in this condition. Regular monitoring of blood sugar levels through comprehensive metabolic testing can help identify these underlying issues early.
Interestingly, the severity of necrobiosis lipoidica doesn't always correlate with blood sugar control. Some patients with well-controlled diabetes still develop NL, while others with poor glycemic control never experience it. This suggests that additional factors beyond glucose levels contribute to its development.
Metabolic Factors Beyond Glucose
While glucose metabolism plays a central role, other metabolic factors may contribute to NL development. Insulin resistance, even without overt diabetes, has been implicated in some cases. Additionally, lipid abnormalities, particularly elevated triglycerides and altered cholesterol profiles, may contribute to the vascular changes underlying this condition.
Recognizing the Signs and Symptoms
Necrobiosis lipoidica typically begins as one or more small, firm, reddish-brown papules or nodules on the shins. Over weeks to months, these lesions expand outward while the center becomes depressed and takes on a distinctive yellow-brown, waxy appearance. The surface appears shiny and atrophic, with visible blood vessels (telangiectasia) often apparent through the thinned skin.
- Initial presentation: Small (3-6mm), firm, red-brown bumps on the shins
- Progression: Lesions expand to form irregular plaques 1-25 cm in diameter
- Mature appearance: Yellow-brown center with raised, reddish-purple borders
- Texture: Shiny, waxy, atrophic surface with visible blood vessels
- Distribution: Usually bilateral on the shins, but can occur on arms, trunk, or face
- Symptoms: Often asymptomatic, but may be itchy, painful, or develop ulcers
The condition progresses slowly and can remain stable for years. However, approximately 35% of cases develop ulceration, particularly after minor trauma. These ulcers can be difficult to heal and may become secondarily infected, requiring careful wound management.
Underlying Causes and Risk Factors
Vascular and Inflammatory Mechanisms
The exact pathophysiology of necrobiosis lipoidica remains incompletely understood, but several mechanisms appear to contribute. Microangiopathy, or small vessel disease, is a central feature. Blood vessels in affected areas show thickening of vessel walls, endothelial cell damage, and impaired blood flow. This vascular compromise may trigger an inflammatory cascade involving immune cells like macrophages and T-lymphocytes.
The inflammatory process leads to degradation of collagen and elastic fibers in the dermis, resulting in the characteristic atrophic appearance. Abnormal glycosaminoglycan deposition and altered fibroblast function further contribute to the tissue changes. Some researchers propose that immune complex deposition or antibody-mediated vasculitis may initiate the process in susceptible individuals.
Genetic and Environmental Factors
While no specific genetic mutations have been identified for NL, familial clustering has been reported, suggesting a hereditary component. Environmental factors that may trigger or exacerbate the condition include trauma (Koebner phenomenon), where new lesions develop at sites of injury. Cold temperatures and poor circulation may also worsen existing lesions.
Upload your blood test results to track your progress
Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.
Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.
Upload Past Blood Test Results
Click or drag file to upload
Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.
Diagnostic Approach
Diagnosis of necrobiosis lipoidica is primarily clinical, based on the characteristic appearance and location of lesions. However, confirming the diagnosis and ruling out other conditions often requires additional testing. A skin biopsy may be performed, showing distinctive histological features including necrobiosis (degeneration) of collagen, granulomatous inflammation, and thickened blood vessel walls.
Given the strong association with diabetes, comprehensive metabolic testing is essential for anyone diagnosed with NL. This should include fasting glucose, hemoglobin A1c, and ideally a full metabolic panel to assess for prediabetes or undiagnosed diabetes. Understanding your complete metabolic profile through regular biomarker testing can help identify underlying issues that may be contributing to skin manifestations.
- Complete blood count to rule out infection or other systemic conditions
- Comprehensive metabolic panel including glucose and kidney function
- Lipid profile to assess cardiovascular risk
- Thyroid function tests if autoimmune conditions are suspected
- Inflammatory markers like C-reactive protein
- Consider autoantibody testing if other autoimmune features are present
Treatment Strategies and Management
Topical and Intralesional Therapies
Treatment of necrobiosis lipoidica can be challenging, as no single therapy works for all patients. First-line treatments typically include potent topical corticosteroids applied twice daily to active lesion borders. These can help reduce inflammation and may prevent lesion expansion. Intralesional corticosteroid injections (triamcinolone acetonide) into the active borders can be more effective than topical application but carry risks of further skin atrophy.
Other topical options include calcineurin inhibitors like tacrolimus, which may be particularly useful for facial lesions or when steroids are contraindicated. Topical retinoids have shown some benefit in improving the appearance of atrophic areas.
Systemic Treatments
For extensive or refractory cases, systemic therapies may be necessary. Options include oral corticosteroids (though rebound can occur), antimalarials like hydroxychloroquine, and immunosuppressants such as cyclosporine or mycophenolate mofetil. Pentoxifylline, which improves blood flow and has anti-inflammatory properties, has shown promise in some studies.
Newer biologic therapies targeting specific inflammatory pathways, including TNF-alpha inhibitors and IL-12/23 inhibitors, have shown success in case reports. Phototherapy with PUVA or narrowband UVB may also be beneficial for some patients.
Living with Necrobiosis Lipoidica
Managing necrobiosis lipoidica requires a comprehensive approach addressing both the skin condition and any underlying metabolic issues. Protecting affected areas from trauma is crucial, as even minor injuries can lead to ulceration. This means wearing protective clothing, avoiding activities that might cause leg injuries, and being careful during daily activities.
For those with diabetes or prediabetes, optimizing blood sugar control is essential, though it may not directly improve existing lesions. Regular monitoring through blood tests and potentially continuous glucose monitoring can help maintain stable glucose levels. Working with an endocrinologist or diabetes specialist to fine-tune medication regimens may be beneficial.
If you're interested in understanding your complete metabolic health picture and tracking improvements over time, comprehensive biomarker testing can provide valuable insights into glucose metabolism, inflammation markers, and overall health status. Upload your existing blood test results for a free analysis to better understand your metabolic health and receive personalized recommendations.
Psychological and Cosmetic Considerations
The visible nature of NL lesions can significantly impact quality of life and self-esteem. Support groups, either in-person or online, can provide valuable emotional support and practical tips from others living with the condition. Cosmetic camouflage techniques using specialized makeup can help conceal lesions for special occasions.
Some patients benefit from psychological counseling to address anxiety or depression related to their condition. Cognitive-behavioral therapy can be particularly helpful in developing coping strategies and maintaining a positive outlook despite the chronic nature of NL.
Prevention and Long-term Outlook
While necrobiosis lipoidica cannot always be prevented, certain measures may reduce risk or prevent worsening. Maintaining optimal metabolic health through regular exercise, a balanced diet low in processed sugars, and weight management can help reduce the risk of both diabetes and its skin complications. Regular skin checks allow for early detection and treatment of new lesions.
The prognosis for NL varies considerably. Some lesions remain stable for years, while others progress or develop complications. Complete spontaneous resolution occurs in less than 20% of cases, and recurrence is common even after successful treatment. However, with appropriate management, most people with NL can prevent serious complications and maintain good quality of life.
Research into new treatments continues, with promising developments in targeted biological therapies and improved understanding of the underlying mechanisms. Clinical trials investigating novel approaches offer hope for more effective treatments in the future. Staying informed about your metabolic health through regular testing and working closely with your healthcare team provides the best foundation for managing this challenging condition.
References
- Reid SD, Ladizinski B, Lee K, Baibergenova A, Alavi A. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013;69(5):783-791.[PubMed][DOI]
- Erfurt-Berge C, Dissemond J, Schwede K, et al. Updated results of 100 patients on clinical features and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study. Eur J Dermatol. 2015;25(6):595-601.[PubMed][DOI]
- Hashemi DA, Brown-Joel ZO, Tkachenko E, et al. Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes. JAMA Dermatol. 2019;155(4):455-459.[PubMed][DOI]
- Sibbald C, Reid S, Alavi A. Necrobiosis Lipoidica. Dermatol Clin. 2015;33(3):343-360.[PubMed][DOI]
- Dissemond J, Erfurt-Berge C, Goerge T, et al. Systemic therapies for necrobiosis lipoidica: A systematic review. Dermatol Ther. 2021;34(1):e14457.[PubMed][DOI]
- Lepe K, Salazar FJ. Necrobiosis Lipoidica. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.[Link][PubMed]
Was this article helpful?
Frequently Asked Questions
How can I test my glucose and metabolic markers at home?
Is necrobiosis lipoidica always a sign of diabetes?
Can necrobiosis lipoidica be cured completely?
What triggers necrobiosis lipoidica flare-ups?
Should I see a dermatologist or endocrinologist for necrobiosis lipoidica?
This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.
